Dupilumab treatment in patients with atopic hand and foot dermatitis: results from a phase 3, randomized, double-blind, placebo-controlled trial

被引：1
|
作者：
Simpson, Eric L. [1 ]
Silverberg, Jonathan, I [2 ]
Worm, Margitta [3 ]
Honari, Golara [4 ]
Masuda, Koji [5 ]
Sygula, Ewa [6 ]
Maloney, Jennifer [7 ]
Mannent, Leda P. [8 ]
Xiao, Jing [7 ]
Dubost-Brama, Ariane [8 ]
Bansal, Ashish [7 ]
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR USA
[2] George Washington Sch Med & Hlth Sci, Washington, DC USA
[3] Charite Univ Med Berlin, Berlin, Germany
[4] Stanford Univ, Sch Med, Redwood City, CA USA
[5] Kyoto Prefectural Univ Med, Kyoto, Japan
[6] Andrzej Mielecki Mem Independent Publ Clin Hosp, Katowice, Poland
[7] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[8] Sanofi, Chilly Mazarin, France
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2023年 / 188卷
关键词：
dupilumab; moderate-to-severe; hand; foot; dermatitis;
D O I：
10.1093/bjd/ljad162.029
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
408
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Randomized double-blind, placebo-controlled trial evaluating oral glutamine on radiation-induced oral mucositis and dermatitis in head and neck cancer patients
    Huang, Chih-Jen
    Huang, Ming-Yii
    Fang, Pen-Tzu
    Chen, Frank
    Wang, Yu-Tsang
    Chen, Chung-Ho
    Yuan, Shyng-Shiou
    Huang, Chun-Ming
    Luo, Kuei-Hau
    Chuang, Hung-Yi
    Wang, Yen-Yun
    Lee, Hsin-Hua
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2019, 109 (03) : 606 - 614
  • [22] Rocatinlimab Improves Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis: Results from a Double-Blind Placebo-Controlled Phase 2b Study
    Gooderham, Melinda
    Guttman-Yassky, Emma
    Igawa, Ken
    Kabashima, Kenji
    Esfandiari, Ehsanollah
    Rylands, Angela J.
    Williams, Angela
    Nixon, Annabel
    Dent, Jennifer E.
    Simpson, Eric
    DERMATOLOGY AND THERAPY, 2024, 14 (12) : 3351 - 3366
  • [23] Immunogenicity, Safety, and Immune Persistence of a Novel Inactivated Human Enterovirus 71 Vaccine: A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial
    Li, Yan-Ping
    Liang, Zheng-Lun
    Xia, Jie-Lai
    Wu, Jun-Yu
    Wang, Ling
    Song, Li-Fei
    Mao, Qun-Ying
    Wen, Shu-Qun
    Huang, Ren-Guo
    Hu, Yuan-Sheng
    Yao, Xin
    Miao, Xu
    Wu, Xing
    Li, Rong-Cheng
    Wang, Jun-Zhi
    Yin, Wei-Dong
    JOURNAL OF INFECTIOUS DISEASES, 2014, 209 (01) : 46 - 55
  • [24] Safety and Activity of UR-1505 in Atopic Dermatitis: A Randomized, Double-blind Phase II Exploratory Trial
    Vives, Roser
    Pontes, Caridad
    Sarasa, Maria
    Millier, Aurelie
    CLINICAL THERAPEUTICS, 2015, 37 (09) : 1955 - 1965
  • [25] Rapid Improvement in Skin Pain Severity and Its Impact on Quality of Life in Adult Patients With Moderate-to-Severe Atopic Dermatitis From a Double-Blind, Placebo-Controlled Baricitinib Phase 3 Study
    Rosmarin, David
    Fretzin, Scott
    Strowd, Lindsay
    Casillas, Marta
    DeLozier, Amy M.
    Dawson, Zach
    Chen, Sherry
    Lu, Na
    Thyssen, Jacob P.
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2022, 26 (04) : 377 - 385
  • [26] Dupilumab does not affect correlates of vaccine-induced immunity: A randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitis
    Blauvelt, Andrew
    Simpson, Eric L.
    Tyring, Stephen K.
    Purcell, Lisa A.
    Shumel, Brad
    Petro, Christopher D.
    Akinlade, Bolanle
    Gadkari, Abhijit
    Eckert, Laurent
    Graham, Neil M. H.
    Pirozzi, Gianluca
    Evans, Robert
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 80 (01) : 158 - +
  • [27] Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe Asthma
    Busse, William W.
    Maspero, Jorge F.
    Rabe, Klaus F.
    Papi, Alberto
    Wenzel, Sally E.
    Ford, Linda B.
    Pavord, Ian D.
    Zhang, Bingzhi
    Staudinger, Heribert
    Pirozzi, Gianluca
    Amin, Nikhil
    Akinlade, Bolanle
    Eckert, Laurent
    Chao, Jingdong
    Graham, Neil M. H.
    Teper, Ariel
    ADVANCES IN THERAPY, 2018, 35 (05) : 737 - 748
  • [28] Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe Asthma
    William W. Busse
    Jorge F. Maspero
    Klaus F. Rabe
    Alberto Papi
    Sally E. Wenzel
    Linda B. Ford
    Ian D. Pavord
    Bingzhi Zhang
    Heribert Staudinger
    Gianluca Pirozzi
    Nikhil Amin
    Bolanle Akinlade
    Laurent Eckert
    Jingdong Chao
    Neil M. H. Graham
    Ariel Teper
    Advances in Therapy, 2018, 35 : 737 - 748
  • [29] Benralizumab effect on severe chronic rhinosinusitis with nasal polyps (CRSwNP): A randomized double-blind placebo-controlled trial
    Tversky, Jody
    Lane, Andrew P.
    Azar, Antoine
    CLINICAL AND EXPERIMENTAL ALLERGY, 2021, 51 (06) : 836 - 844
  • [30] Early botulinum toxin treatment for spastic pes equinovarus - a randomized double-blind placebo-controlled study
    Fietzek, U. M.
    Kossmehl, P.
    Schelosky, L.
    Ebersbach, G.
    Wissel, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 (08) : 1089 - 1095
12345